Today in Law
Latest News
<![CDATA[Durvalumab Plus Chemo Yields Inconclusive Results in Advanced Pleural Mesothelioma]]>
Durvalumab (Imfinzi) in combination with chemotherapy produced outcomes consistent with prior studies in patients with advanced pleural mesothelioma, demonstrating favorable overall survival (OS), progression-free survival (PFS), and objective...
Owner: Mike Hennessy Jr.
<![CDATA[Durvalumab Combo Shows Consistent Outcomes in Advanced Pleural Mesothelioma]]>
Although slow accrual and standard-of-care practice changes yielded inconclusive results in the phase 3 DREAM3R trial (NCT04334759, ACTRN12620001199909), frontline durvalumab (Imfinzi) plus chemotherapy nevertheless produced consistent overall...
Owner: Mike Hennessy Jr.
<![CDATA[Imfinzi With Chemo Produces Inconclusive Outcomes in Phase 3 Mesothelioma Study]]>
In the phase 3 DREAM3R study, first-line treatment with Imfinzi (durvalumab) plus chemotherapy demonstrated consistent improvements in overall survival, progression-free survival, and objective response rates among patients with advanced pleural...
Owner: Mike Hennessy Jr.
<![CDATA[Durvalumab/Chemotherapy Prove Inconclusive in Phase 3 for Mesothelioma]]>
In the phase 3 DREAM3R trial (NCT04334759, ACTRN12620001199909), first-line durvalumab (Imfinzi) plus chemotherapy demonstrated consistent overall survival (OS), progression-free survival (PFS), and objective response rates (ORR)benefits in...
Owner: Mike Hennessy Jr.
ESMO 2025: VT3989 Continues to Show Promising Early Results in Patients with Advanced Mesothelioma
VT3989 is a first-in-class YAP-TEAD inhibitor from Vivace Therapeutics that is currently in Phase I/II trials for patients with advanced solid tumors, with a focus on refractory mesothelioma In this trial, VT3989 demonstrated notable antitumor...
Owner: Roger Johnson (daughter Jessica is CEO)
ESMO 2025: VT3989 Demonstrates Promising Early Outcomes in Advanced Mesothelioma Patients
In a groundbreaking advancement in oncology, researchers from The University of Texas MD Anderson Cancer Center have unveiled promising results from clinical trials of VT3989, a first-in-class YAP-TEAD inhibitor targeting advanced solid tumors...
Owner: Non-transparent
VT3989, Vivace Therapeutics' Best-in-Class, Hippo Pathway-Targeting Therapy, Demonstrates Promising Antitumor Activity in Refractory Mesothelioma
Neutral
WFMZ - Pennsylvania
·
Latest Data from Phase I/II Study Reported in an Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 2025 and Published Concurrently in Nature Medicine VT3989 Achieves 32% Overall Response Rate, 86% Disease Control Rate,...
Owner: Richard Dean
Guest Opinion: A national mesothelioma registry could significantly enhance health outcomes for Utah veterans
Indeterminate
The Daily Utah Chronicle
·
For most of the 20th century, asbestos — a naturally occurring mineral — was widely used across all branches of the US military. It was embedded in numerous materials used in the construction and maintenance of planes, ships, tanks, trucks, and...
Owner: The University of Utah
What to Consider Before Finding a Mesothelioma Law Firm
Hiring a mesothelioma law firm is one of the biggest decisions you or your family can make after a diagnosis. Mesothelioma is a rare and aggressive form of cancer caused by asbestos exposure, and legal cases involving it are often complex. A...
Owner: Rick Weinberg
Johnson & Johnson Hit With Record $966 Million Verdict In Los Angeles Mesothelioma Cancer Case
In what appears to be the largest mesothelioma verdict in history, a Los Angeles jury has ordered Johnson & Johnson to pay $966 million to the family of a woman who died from the rare and aggressive cancer. The case, filed by the family of Mae...
Owner: Nduka Obaigbena
A National Mesothelioma Registry is Urgently Needed for Bandera County Veterans
While often classified as a rare disease, mesothelioma represents a growing and serious public health challenge, particularly for U.S. veterans. This aggressive and deadly form of cancer, caused exclusively by long-term exposure to asbestos,...
Owner: Daniel Philhower
FDA Puts VT3989 on the “Fast Track” for Mesothelioma
In October 2025, the U.S. Food and Drug Administration (FDA) granted Fast Track designation to a new treatment called VT3989 for people with unresectable (inoperable) mesothelioma. This applies to patients whose cancer has continued to grow after...
Owner: Chris Carberg
Knox County veterans battle hidden cost of service − mesothelioma
Neutral
The Knoxville News-Sentinel - Tennessee
·
Mesothelioma, an aggressive and fatal cancer, continues to affect thousands of Americans, but veterans remain among the hardest affected. The main issue for affected veterans is that mesothelioma is very difficult to detect in its early stages....
Owner: Gannett Co. Inc.
17th annual Alton Miles for Meso Run/Walk raises $25K for mesothelioma awareness
Shown from left to right at the check presentation are William Bowens, Miles for Meso Committee; Jordan Zevon; Linda Reinstein, ADAO president; “Miles”; Todd Adamitis, Miles for Meso Committee chair and Simmons Hanly Conroy COO; and Ellen Costa,...
Owner: Scott Hoskins
It’s still killing people, and the government has yet to act: Britain’s hidden asbestos epidemic
Helen Bone was diagnosed with an asbestos-related cancer in 2021. She was 38. The type of cancer, mesothelioma, is incurable; the best prognosis is a few years, though most people don’t get that long. “You always think of asbestos as a disease...
Owner: The Scott Trust
<![CDATA[FDA Grants Fast Tract Designation to VT3989 for Mesothelioma]]>
The U.S. Food and Drug Administration (FDA) has granted fast track designation to VT3989, a novel investigational small molecule cancer therapeutic, for the treatment of patients with unresectable malignant nonpleural or pleural mesothelioma whose...
Owner: Mike Hennessy Jr.
AlphaTON Capital Explodes on Game-Changing Tokenization Play in the Fight Against Mesothelioma
Folks, if you’re glued to the markets this morning, you’ve probably noticed one name lighting up the board like a fireworks show: AlphaTON Capital Corp (Nasdaq: ATON). As of this writing, early in the trading session on October 8, 2025, shares are...
Owner: Jason Bond & Jeff Bishop
<![CDATA[FDA Grants Fast Track Designation to VT3989 for Unresectable Mesothelioma]]>
The FDA has granted fast track designation to VT3989, a transcriptional enhanced associate domain (TEAD) autopalmitoylation inhibitor, for the treatment of patients with unresectable malignant nonpleural or pleural mesothelioma who have progressed...
Owner: Mike Hennessy Jr.
One in three asbestos inspection firms in the Netherlands are failing to ensure safety
The Dutch Labor Inspectorate warns that over a third of the 18 certified companies responsible for post-asbestos removal inspections fail to do their jobs correctly, leading to buildings being declared safe despite lingering asbestos residues. The...
Owner: Zachary Newmark
Judge Increases Mesothelioma Verdict Against Johnson & Johnson
A Connecticut judge has added more money to a jury’s verdict award for a plaintiff with mesothelioma who filed suit against Johnson & Johnson. A Bridgeport Superior Court jury initially awarded Evan Plotkin $15 million in October 2024. The judge...
Owner: Raymond Gene Apelado
Today in Law
Press Releases
Safe and Seamless Solution: How Epoxy Coatings Are Revolutionizing Asbestos Tile Encapsulation
Why Epoxy Flooring Is the Ideal Encapsulation Method FAIRFIELD, NJ, UNITED STATES, October 20, 2025 /EINPresswire.com/ -- Asbestos-containing tiles are a pervasive issue in older commercial, industrial, and institutional buildings. Property...
AlphaTON Capital and Subsidiary Cyncado Therapeutics Pioneer Convergence of Digital Assets and Oncology Innovation: Exploring Tokenization Framework for Mesothelioma Program as it Advances Toward Q1 2026 First Patient Dosing
Dover, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) ("AlphaTON" or the "Company"), alongside its wholly owned oncology subsidiary Tarus Therapeutics, LLC (dba Cyncado Therapeutics) ("Cyncado"), today announced a...
Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma
Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma Paris, France, June 4th, 2025. Oncovita, a biotechnology company developing innovative virus-based...
Leading Factor Driving The Malignant Mesothelioma Market In 2025: Rising Clinical R&D Efforts Driving Market Growth
The Business Research Company's Malignant Mesothelioma Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 13, 2025 /EINPresswire.com/ -- The Business Research Company’s...
Louisiana Mesothelioma Victims Center Urges the Family of a Former Chemical Plant-Refinery Worker with Mesothelioma or Lung Cancer in Louisiana to Call the Gori Law Firm-Expect Better Compensation Results
NEW ORLEANS, LA, UNITED STATES, May 15, 2025 /EINPresswire.com/ -- The Louisiana Mesothelioma Victims Center is urging the family of a former chemical plant or refinery worker who has just learned they have mesothelioma or lung cancer to please...
Florida Mesothelioma Victims Center Strongly Recommends the Gori Law Firm for a Former Plumber with Mesothelioma or Lung Cancer Anywhere in Florida-Hire Better Lawyers-Get Better Compensation
TAMPA , FL, UNITED STATES, May 13, 2025 /EINPresswire.com/ -- The Florida Mesothelioma Victims Center says, "If your husband or dad who now lives in Florida was a plumber and he has recently been diagnosed with mesothelioma or lung cancer we...
Louisiana Mesothelioma Victims Center Urges a Former Shipyard or Barge Worker with Mesothelioma or Lung Cancer in Louisiana to Call the Gori Law Firm-Expect Better Compensation Results
NEW ORLEANS , LA, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- The Louisiana Mesothelioma Victims Center says, "If your loved one is a former shipyard or barge worker anywhere in Louisiana and they now have mesothelioma or lung cancer please...
Florida Mesothelioma Victims Center Has Endorsed the Gori Law Firm for the Family of a Former Welder with Mesothelioma or Lung Cancer in Florida-Hire Better Lawyers-Get Better Compensation Results
ORLANDO , FL, UNITED STATES, May 6, 2025 /EINPresswire.com/ -- According to the Florida Mesothelioma Victims Center, "If your husband or dad is a former welder and he has just been diagnosed with mesothelioma or lung cancer please call the...
Louisiana Mesothelioma Victims Center Urges the Family of a Journeyman Plumber Who Now Has Mesothelioma or Lung Cancer in Louisiana to Call the Gori Law Firm-Expect Better Compensation Results
NEW ORLEANS, LA, UNITED STATES, May 1, 2025 /EINPresswire.com/ -- The Louisiana Mesothelioma Victims Center says, "We are urging the family of a former journeyman plumber who has just been diagnosed with mesothelioma or lung cancer in Louisiana...
Florida Mesothelioma Victims Center Urges the Family of a Mechanic Who Has Just been Diagnosed with Mesothelioma or Lung Cancer in Florida to Call the Gori Law Firm About Compensation-Better Attorneys Better Results
TAMPA, FL, UNITED STATES, April 29, 2025 /EINPresswire.com/ -- The Florida Mesothelioma Victims Center is urging the family of a mechanic who has recently been diagnosed with mesothelioma or lung cancer anywhere in Florida to please call the...
Primary Ovarian Mesothelioma: A Rare Tumor and a Rare Person Who is a ‘Unicorn’
Primary ovarian mesothelioma is a rare tumor linked to asbestos/talc exposure, often misdiagnosed, with survivors enduring lasting impacts SANTA BARBARA, CA, UNITED STATES, April 21, 2025 /EINPresswire.com/ -- “Primary ovarian mesothelioma is a...
Louisiana Mesothelioma Victims Center Urges a Day Laborer in Louisiana Who Now Has Mesothelioma or Lung Cancer to Please Call the Gori Law Firm About Compensation-It Might Be Much More Than They Think
NEW ORLEANS, LA, UNITED STATES, April 24, 2025 /EINPresswire.com/ -- The Louisiana Mesothelioma Victims Center is urging a person in Louisiana who was a day laborer decades ago and has just been diagnosed with mesothelioma or lung cancer to...
Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7
DOVER, Del., April 28, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company today reports confirmatory preclinical efficacy data for PORT-7 (TT-4), a selective adenosine A2B receptor inhibitor. Dr....
Florida Mesothelioma Victims Center Urges a Baby Powder-Talcum Powder User Who Now Has Mesothelioma or Lung Cancer in Florida to Call the Gori Law Firm About a Much Better Financial Compensation Result
ORLANDO , FL, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- The Florida Mesothelioma Victims Center says, "If your son, daughter or mom has just been diagnosed with mesothelioma or lung cancer in Florida and they have been using...
Malignant Pleural Mesothelioma Market Poised for Growth Across the 7MM During the Study Period (2020–2034) Amid Advances in Immunotherapy and Targeted Drugs | DelveInsight
New York, USA, April 21, 2025 (GLOBE NEWSWIRE) -- Malignant Pleural Mesothelioma Market Poised for Growth Across the 7MM During the Study Period (2020–2034) Amid Advances in Immunotherapy and Targeted Drugs | DelveInsight The malignant pleural...
Louisiana Mesothelioma Victims Center Urges a Navy Veteran Who Spent Time at a Shipyard and Who Now Has Mesothelioma or Lung Cancer in Louisiana to Call the Gori Law Firm About Compensation and Better Results
NEW ORLEANS, LA, UNITED STATES, April 17, 2025 /EINPresswire.com/ -- The Louisiana Mesothelioma Victims Center says, "If your loved one in Louisiana is a navy veteran and they spent time in a shipyard with their ship or submarine and they now...
Florida Mesothelioma Victims Center Has Endorsed the Gori Law Firm for a School-Hospital Maintenance Worker Who Has Developed Mesothelioma or Lung Cancer Anywhere in Florida-Expect Better Compensation Results
TAMPA, FL, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- The Florida Mesothelioma Victims Center is appealing to the loved ones of a former school or hospital maintenance-repair person who has just been diagnosed with mesothelioma to focus...
Er-Kim Announces Exclusive Distribution Agreement with Polaris Pharmaceuticals to Commercialize Pegargiminase (ADZODI) for Malignant Pleural Mesothelioma (MPM) in Multiple EMEA Markets
ATHENS, Greece and SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Er-Kim Pharmaceuticals, an international company specializing in the commercialization of novel therapies for pharmaceutical and biopharmaceutical companies, today announced it has...
Louisiana Mesothelioma Victims Center Recommends the Gori Law Firm to the Family of a Former Oil Refinery Worker with Mesothelioma or Lung Cancer in Louisiana-Expect Better Compensation Results
NEW ORLEANS, LA, UNITED STATES, April 10, 2025 /EINPresswire.com/ -- The Louisiana Mesothelioma Victims Center highly recommends the Gori Law Firm to the family of a former oil refinery worker with recently diagnosed mesothelioma or lung cancer...
Florida Mesothelioma Victims Center Appeals to the Family of a Career Navy Veteran with Just Diagnosed Mesothelioma or Lung Cancer in Florida to call the Gori Law Firm-Hire More Qualified Lawyers--Get Better Compensation
MIAMI , FL, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- The Florida Mesothelioma Victims Center says, "If your husband or dad is a career navy veteran and they have just been diagnosed with mesothelioma or lung cancer anywhere in Florida...